Stonepine Capital Management, LLC 13D and 13G filings for Catalyst Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 5:55 pm Sale |
2021-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
Stonepine Capital Management, LLC | 0 0.000% |
-543,781 (Position Closed) |
Filing |
| 2021-02-18 7:48 pm Purchase |
2021-01-27 | 13G | Catalyst Biosciences, Inc. CBIO |
Stonepine Capital Management, LLC | 543,781 6.900% |
332,221 (+157.03%) |
Filing |
| 2021-02-12 5:00 pm Sale |
2020-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
Stonepine Capital Management, LLC | 211,561 3.800% |
-51,920 (-19.71%) |
Filing |
| 2020-08-05 4:09 pm Purchase |
2020-03-03 | 13G | Catalyst Biosciences, Inc. CBIO |
Stonepine Capital Management, LLC | 263,481 6.000% |
263,481 (New Position) |
Filing |